Log in to save to my catalogue

Integrated stem cell signature and cytomolecular risk determination in pediatric acute myeloid leuke...

Integrated stem cell signature and cytomolecular risk determination in pediatric acute myeloid leuke...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_25d98e54e2234ca19a9e20931766c2ae

Integrated stem cell signature and cytomolecular risk determination in pediatric acute myeloid leukemia

About this item

Full title

Integrated stem cell signature and cytomolecular risk determination in pediatric acute myeloid leukemia

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2022-09, Vol.13 (1), p.5487-5487, Article 5487

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Relapsed or refractory pediatric acute myeloid leukemia (AML) is associated with poor outcomes and relapse risk prediction approaches have not changed significantly in decades. To build a robust transcriptional risk prediction model for pediatric AML, we perform RNA-sequencing on 1503 primary diagnostic samples. While a 17 gene leukemia stem cell s...

Alternative Titles

Full title

Integrated stem cell signature and cytomolecular risk determination in pediatric acute myeloid leukemia

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_25d98e54e2234ca19a9e20931766c2ae

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_25d98e54e2234ca19a9e20931766c2ae

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-022-33244-6

How to access this item